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Introduction: Chronic hepatitis B virus and schistosomiasis are independently associated with significant mortality
and morbidity worldwide. Despite much geographic overlap between these conditions and no reason why
co-infection should not exist, we present what is, to the best of our knowledge, the first published report of a
proven histological diagnosis of hepatic Schistosomiasis japonicum and chronic hepatitis B co-infection. A single
case of hepatitis B and hepatic Schistosomiasis mansoni diagnosed by liver biopsy has previously been reported in
the literature.
Case presentation: A 38-year-old Chinese man with known chronic hepatitis B virus infection presented with
malaise, nausea and headache. Blood tests revealed increased transaminases and serology in keeping with hepatitis
B virus e-antigen seroconversion. A liver biopsy was performed because some investigations, particularly transient
elastography, suggested cirrhosis. Two schistosome ova were seen on liver histology, identified as S. japonicum,
probably acquired in China as a youth. His peripheral eosinophil count was normal, schistosomal serology and stool
microscopy for ova, cysts and parasites were negative.
Conclusion: Hepatic schistosomiasis co-infection should be considered in patients with hepatitis B virus infection
who are from countries endemic for schistosomiasis. Screening for schistosomiasis using a peripheral eosinophil
count, schistosomal serology and stool microscopy may be negative despite infection, therefore presumptive
treatment could be considered. Transient elastography should not be used to assess liver fibrosis during acute flares
of viral hepatitis because readings are falsely elevated. The impact of hepatic schistosomiasis on the sensitivity and
specificity of transient elastography measurement for the assessment of hepatitis B is as yet unknown.
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The geographical distributions of hepatitis B virus
(HBV) and schistosomiasis overlap, and therefore co-
infection may occur in patients. The ova of S. mansoni
and S. japonicum reach the liver via the portal venous
system and cause inflammation, leading to fibrosis
and portal hypertension. It is possible to see schisto-
some ova on liver histology, but this has rarely been* Correspondence: victoria.parris@rlbuht.nhs.uk
1Tropical and Infectious Disease Unit, Royal Liverpool University Hospital,
Prescot Street, Liverpool, Merseyside L7 8XP, UK
Full list of author information is available at the end of the article
© 2014 Parris et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
waiver (http://creativecommons.org/publicdom
stated.reported in the literature [1]. We present the case of a
38-year-old Chinese man with dual pathology of HBV
e-antigen seroconversion causing acute liver inflamma-
tion and hepatic S. japonicum found incidentally on a
liver biopsy.Case presentation
A 38-year-old Chinese man presented with a three-week
history of anorexia, nausea and headache. He had been
resident in the UK for 11 years and had been diagnosed
with chronic HBV infection six months previously, at
which time he was positive for hepatitis B surfacetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Liver biopsy, scanned hematoxylin and eosin image ×
10 magnification. The schistosome ovum (arrowed) is situated next
to a small bile duct and surrounded by inflammatory cells including
lymphocytes and plasma cells. The inflammation involves a
collapsed area of liver parenchyma; an adjacent nodule of
hepatocytes is present. A portal tract in longitudinal section is
present above the ovum.
Figure 2 Schistosome ovum within liver biopsy, scanned
hematoxylin and eosin image × 40 magnification.
The schistosome ovum (arrowed) is non-operculated and
thin-walled, measuring 79.2μm×48μm, morphologically consistent
with Schistosomiasis japonicum.
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only other past medical history was of gastritis for which
he had received Helicobacter pylori eradication therapy,
and his only medication was lansoprazole. He occasion-
ally drank alcohol and had a brother in China who also
had chronic hepatitis B infection.
On examination, he had no stigmata of chronic liver dis-
ease and no hepatosplenomegaly. His admission blood test
results demonstrated a rise in alanine aminotransferase
(ALT) from 88U/L at diagnosis to 671U/L. His bilirubin
level was 44μmol/L, alkaline phosphatase 125U/L, and
gamma-glutamyl transpeptidase 125U/L. His level of
albumin was normal at 38g/L. Clotting was mildly de-
ranged (prothrombin time, 16.9 seconds; activated partial
thromboplastin time, 45.6 seconds). A full blood count
confirmed a longstanding thrombocytopenia (platelets,
69×109/L) with a normal white blood cell differential.
His viral serology at the time of admission demonstrated
that he had remained hepatitis B surface antigen positive,
but was now e-antibody positive with persisting e-antigen,
in keeping with e-antigen seroconversion. His hepatitis
B viral load was high at log 8.3 (1.9×108IU/mL). Serol-
ogy also demonstrated previous hepatitis A, hepatitis E,
Epstein-Barr virus and cytomegalovirus infections. Hepa-
titis C and hepatitis D serologies were negative, as were
liver autoantibodies.
An abdominal ultrasound scan demonstrated normal
appearances of his liver and spleen with hepatopetal
portal vein flow. Transient elastography (TE, FibroScan®)
was performed (10 readings with 100% success, inter-
quartile range/median value of 38.5%) with liver stiff-
ness of 69.1kPa, consistent with liver cirrhosis (Metavir
classification F4). Because of conflicting imaging results
and biochemical markers in keeping with cirrhosis, we
proceeded to an ultrasound-guided liver biopsy, the
results of which were unexpected. The liver biopsy
consisted of a 25mm core of tissue that included parts
of 16 portal tracts. The architecture appeared nodular,
which was due to parenchymal collapse as opposed
to fibrosis, and this was accompanied by a patchy in-
flammatory cell infiltrate compromising lymphocytes,
plasma cells and a small number of eosinophils. The
appearance was of acute hepatitis but not specific with
respect to its etiology. In addition, two ova were noted.
These were non-operculated and thin-walled, measur-
ing 79.2μm×48μm and 57.6μm×36μm, morphologically
consistent with S. japonicum (Figures 1 and 2). There
was no accompanying granulomata or pipestem fibro-
sis. Stool and urine microscopy did not identify any
ova, cysts or parasites, and schistosomal serology was
negative. His peripheral eosinophil count was normal
(0.1×109/L).
Our patient had grown up in Hubei province, China,
and had not travelled abroad until moving to the UK 11years ago. Since then he had returned to China on mul-
tiple occasions and had travelled within Europe. As an
adolescent he had worked in paddy fields, a potential
epidemiological exposure risk for S. japonicum, although
this exposure was a long time in the past. Following the
liver biopsy result, he was treated for schistosomiasis
with 60mg/kg praziquantel in a single dose. At the time
of treatment, his ALT level had significantly improved
Parris et al. Journal of Medical Case Reports 2014, 8:45 Page 3 of 5
http://www.jmedicalcasereports.com/content/8/1/45from a peak of 730U/L to 250U/L. Three months later,
his ALT had normalized (30U/L) and hepatitis B ser-
ology continued to be in keeping with e-antigen sero-
conversion; his surface antigen remained positive, his
viral load fell to log 4.8 (63,852IU/mL), and although his
e-antibody was equivocal, he was only weakly positive
for e-antigen.
Discussion
Worldwide, over two billion people have been infected
with viral hepatitis B, with an estimated 240 million
people chronically infected, and 600,000 attributable
deaths per year [2]. China is a highly endemic country
although prevalence is decreasing with improved cover-
age of HBV vaccination of infants. Hepatitis B surface
antigen prevalence decreased by 9.8% over 14 years to
7.2% in 2006, with a prevalence of 1% in children under
five years [3]. However, variation occurs within China,
particularly relating to ethnic group, education level and
geography, with higher prevalence in the west compared
to the east [3].
There are five species of schistosomes that can infect
humans: S. mansoni, S. haematobium, S. japonicum, S.
mekongi and S. intercalatum. In 2011, at least 243 mil-
lion people required treatment for schistosomiasis, with
transmission occurring in 78 countries [4]. S. japoni-
cum is the only species infecting humans that is en-
demic to China, present in an area stretching from the
China Sea to the Burmese border, along the course of
the Yangzi river and upper Mekong delta [5]. At the
peak prevalence of schistosomiasis in China during
the 1950s, the highest prevalence of S. japonicum was
found on alluvial deposits of the Yangzi river, including
the Hubei province where our patient grew up [5].
Since the introduction of a control program in the
1950s, prevalence has decreased, but distribution of
S. japonicum remains linked to agricultural areas using
irrigation for rice cultivation, with seasonal peaks in
transmission corresponding to spring floods and reced-
ing waters in autumn [5].
Few and conflicting data currently exist as to whether
there is an interaction between HBV and schistosomia-
sis, with no current consensus [6]. Postulated reasons
for the two infections co-existing include impaired
cell-mediated immunity reducing host resistance; re-
use of needles for parenteral treatment of schistosomia-
sis; and socioeconomic reasons, that is, those living
in poverty have increased exposure to both viral hepa-
titis and schistosomiasis and so the two co-exist [6].
Studies suggest that patients with S. mansoni infection
have a prolonged clearance rate of hepatitis B surface
antigen, with Bassily et al. finding that patients with
decompensated hepatosplenic schistosomiasis had a
worse outcome if co-infected with HBV, with highertransaminases, more advanced changes on liver hist-
ology and higher mortality [7,8].
TE (FibroScan®) has been developed as a non-invasive,
rapid, painless alternative to liver biopsy. TE measures
liver stiffness, with values ranging from 2.5 to 75kPa.
This value is then extrapolated to indicate the degree of
liver fibrosis or cirrhosis. In our patient, the TE reading
obtained was suggestive of liver cirrhosis, which was
contrary to the findings on clinical examination, ultra-
sound of the liver and liver biopsy. TE has been vali-
dated for the diagnosis of significant fibrosis and
cirrhosis in chronic hepatitis B and chronic hepatitis C,
however it has limitations. Liver stiffness assessed on TE
may be confounded when ALT is very high because
necroinflammation causes falsely elevated readings of
liver stiffness [9]. A study by Coco et al. of 10 patients
with chronic viral hepatitis and acute exacerbations with
ALT flares demonstrated a 1.3- to 3-fold increase in liver
stiffness measurement [10]. Sagir et al. reported that
liver stiffness readings using TE incorrectly suggested
cirrhosis in 15 out of 20 patients with acute liver damage
secondary to varying etiologies, including viral, drug-
induced and autoimmune hepatitis [11]. In the case of
our patient, the falsely elevated liver stiffness measure-
ments would be in keeping with the ALT flare caused by
hepatitis B seroconversion. We could find no published
data on the effect of hepatic schistosomiasis on the val-
idity of the use of TE for the assessment of liver fibrosis
in viral hepatitis. It is possible that the development of
Symmers pipestem fibrosis, the histological hallmark of
hepatic schistosomiasis, could affect liver stiffness read-
ings. This gap in knowledge is important as TE has ad-
vantages over liver biopsy in resource-poor settings
endemic for schistosomiasis, such as portability and
rapid operator training time, although the cost of equip-
ment presents a barrier to its widespread use.
This case also raises the question as to whether im-
migrants and returning travellers should be screened
for schistosomiasis. Although screening for schistosom-
iasis and other parasitic infections is appealing to treat
and prevent their long-term sequelae, the best way
to implement this is not clear. Studies have looked
at the use of eosinophilia, schistosomal serology and
stool microscopy for screening. The degree of periph-
eral eosinophilia in schistosomiasis relates to the stage,
intensity and duration of infection, as well as the host
reaction, limiting its use as an effective screening
tool [12]. Bierman et al. found that a large number
of returned travellers, expatriates and immigrants who
were seropositive for schistosomiasis did not have
an elevated eosinophil count, and the majority of those
with eosinophilia were returned travellers with acute
schistosomiasis, or immigrants with concomitant helminth
infection [13]. Serological detection of schistosomiasis also
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monly used for detection of S. japonicum infection due
to greater availability than S. japonicum egg antigen,
but although there is serological cross-reactivity be-
tween schistosomiasis species, sensitivity is reduced.
Future serological diagnostics may be better - Smith
et al. looked at the use of S. mansoni antigen derived
from schistosomal cerceriae as a cheaper alternative to
S. mansoni soluble egg antigen. They demonstrated
that, for the diagnosis of S. japonicum, it performed as
well as using S. japonicum egg antigen [14]. Epidemio-
logical studies of schistosomiasis use stool and urine
microscopy for the detection of infection. Increased
numbers of Kato Katz smears performed increases
schistosomiasis detection, although the optimum num-
ber of stool examined is debated. A study in Thailand
reported that for all fecal parasites, microscopy of one
stool identified 75% of parasites and two stools, over
90% [15]. Performing multiple stool microscopies is a
labor-intensive process, with the potential for inter-
operator variance, and therefore does not lend itself
well as a screening tool. Hepatic S. japonicum infection
in our patient was found incidentally on liver histology
in the absence of peripheral eosinophilia, and with
negative schistosomal serology and stool microscopy.Conclusion
Whether a relationship between HBV and hepatic schis-
tosomiasis truly exists is not established, with few data
on the impact of co-infection on disease progression, al-
though hepatitis B surface antigen loss is less frequent in
hepatic schistosomiasis co-infection [7].
In this report, we highlight the pitfalls of incorrectly
using TE in the assessment of liver fibrosis during acute
flares of viral hepatitis, when transaminases are grossly
elevated and readings are falsely elevated. The impact of
hepatic schistosomiasis on the sensitivity and specificity
of TE measurement for the assessment of hepatitis B is
as yet unknown, and an area for future work.
Hepatic schistosomiasis co-infection should be con-
sidered in patients infected with HBV from countries
endemic for schistosomiasis. Perhaps, given the limi-
tations of screening for schistosomiasis, and the un-
certainty around the interaction between the two
conditions, these patients should be treated presump-
tively if there are epidemiological reasons to suspect
schistosomiasis.Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying im-
ages. A copy of the written consent is available for re-
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